Johnson Pharmacare Ltd (JOHNPHARMA) is currently trading at 0.46 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Johnson Pharmacare Limited is a pharmaceutical company engaged in purchasing and selling goods and services within India, with a focus on pharmaceuticals. Founded in 1994, originally as Robinson Worldwide Trade Limited, the company underwent several name changes, reflecting shifts in its strategic direction. In 2021, Johnson Pharmacare Limited pivoted its core business towards pharmaceuticals, indicating a significant strategic transition driven by industry opportunities. The company also retains an interest in trading shares and investments, reflecting a diverse yet potentially risky business model. Despite missing investor presentations or concall transcripts, the recent business focus on pharmaceuticals suggests an intent to capitalize on the burgeoning healthcare market.

Over the past 52 weeks, Johnson Pharmacare Ltd has traded between a low of ₹0.45 and a high of ₹0.79. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Johnson Pharmacare Ltd has a market capitalization of approximately 25.30. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Johnson Pharmacare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.45 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 25.30 Cr, Johnson Pharmacare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Johnson Pharmacare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Johnson Pharmacare Ltd is -0.45. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The main announcement is the 'Biopharma Shakti' scheme, with an outlay of Rs. 10,000 crores over five years to make India a global hub for biopharmaceutical manufacturing, focusing on biologics and biosimilars.